Anal Cancer News and Research

RSS

Anal cancer is a type of cancer which arises from the anus, the distal orifice of the gastrointestinal tract. It is a distinct entity from the more common colorectal cancer.

Hispanic and Latino men in sexual minority groups may lack awareness about HPV-related cancers

A study found multiple gaps in awareness and knowledge about the connection between the human papillomavirus (HPV) and several types of cancer among Hispanic and Latino men who identified as sexual minorities, according to results presented at the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 29-October 2, 2023.

29 Sep 2023

Study examines the link between oropharyngeal cancer and high-risk sexual behavior

The development of head and neck cancer is increasingly linked to HPV infection, which is a sexually transmitted disease.

14 Jul 2023

Study aims to optimize radiotherapy treatment for patients with anal cancer

Reducing the dose and duration of radiotherapy treatments for anal cancer may result in fewer side effects, recent clinical trial results have shown.

15 May 2023

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

Institute of Human Virology researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health's National Cancer Institute (NCI) for a total of $7.5 million.

31 Oct 2022

Rutgers study uncovers predictors of anal high-risk HPV infection

Previous sexually transmitted infections and more sexual partners predict new human papillomavirus (HPV) infections in men who have sex with men, other cisgender sexual minority men and transgender women, according to a Rutgers study.

7 Sep 2022

Treatment of precancerous anal growths in HIV patients decreases the progression to anal cancer

A team of researchers, including LSU Health New Orleans Infectious Diseases and Microbiology professor Michael Hagensee, MD, PhD, has shown for the first time that treating precancerous anal growths called high-grade squamous intraepithelial lesions (HSILs) in persons living with HIV significantly decreased the progression to anal cancer.

15 Jul 2022

Nomogram helps predict anal cancer risk in HIV patients

Both cervical and anal cancer are caused by human papillomavirus. Both diseases also share a common precursor: abnormal cells known as high-grade squamous intraepithelial lesions (HSIL).

1 Jul 2022

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than half.

15 Jun 2022

Study finds high rates of cancer among men living with HIV

Researchers with Case Western Reserve University have found that there are nearly twice as many men with cancer among men living with HIV (MLWH) compared to men who do not have the human immunodeficiency virus.

17 Mar 2022

HPV-related cancers increase in U.S. counties with low-income, high smoking prevalence

A new paper in JNCI Cancer Spectrum, published by Oxford University Press, finds increases in both men and women for several HPV-related cancers in low-income counties or those with high smoking rates. Increases were slower in the highest-income US counties or those with low smoking rates.

3 Mar 2022

Time of starting antiretroviral therapy can influence tumor development In HIV patients

HIV patients have an increased risk of developing skin and mucosal cancers, even though HIV is no longer detectable in their blood due to antiretroviral therapy.

23 Nov 2021

Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.

8 Oct 2021

Mount Sinai awarded more than $4 million to evaluate anal cancer screening in high-risk women

The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus (HPV) infection.

10 Aug 2021

Anal Cancer News and Research

Further Reading

Hispanic and Latino men in sexual minority groups may lack awareness about HPV-related cancers

Study examines the link between oropharyngeal cancer and high-risk sexual behavior

Study aims to optimize radiotherapy treatment for patients with anal cancer

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

Rutgers study uncovers predictors of anal high-risk HPV infection

Treatment of precancerous anal growths in HIV patients decreases the progression to anal cancer

Nomogram helps predict anal cancer risk in HIV patients

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

Study finds high rates of cancer among men living with HIV

HPV-related cancers increase in U.S. counties with low-income, high smoking prevalence

Time of starting antiretroviral therapy can influence tumor development In HIV patients

Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

Mount Sinai awarded more than $4 million to evaluate anal cancer screening in high-risk women

Vaccination program reduces HPV-related diseases in gay, bisexual men

Study: Anal intraepithelial neoplasia is a precursor lesion for anal squamous cell carcinomas

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

Study shows potential of new pinprick blood test for diagnosing HPV-related cancers

Research consortium receives $111 million NCI grant to prevent, treat HIV-related cancers

International trial shows better option for treating people with inoperable anal cancer

Study finds carboplatin-paclitaxel as the optimal chemotherapy for anal cancer

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News